QA: Bicycle Therapeutics PLC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001761612_2024_Bicycle_Therapeutics_PLC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}

Graph

Absolute values for 0001761612, Bicycle Therapeutics PLC

  xvar xval
0 AssetsCurrent 561,868,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,515,000
3 remainder_Assets 18,961,000
4 LiabilitiesCurrent 69,537,000
5 LiabilitiesNoncurrent 44,659,000
6 remainder_Liabilities 110,216,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 80,894,813
9 ResearchAndDevelopmentExpense 530,845,407
10 remainder_Expenses 7,475,663
11 remainder_Revenues 26,235,231
12 remainder_NetIncome 9,905,889
13 remainder_ComprehensiveNetIncome 2,289,699
  yvar yval
0 Assets 595,344,000
1 Liabilities 224,412,000
2 Expenses 619,215,883
3 Revenues 26,235,231
4 StockholdersEquity 370,932,000
5 NetIncome -583,074,763
6 ComprehensiveNetIncome -581,929,914
7 BaseVar 738,701,351
8 EconomicCapitalRatiobeforeLimitedLiability 0.553
9 EconomicCapitalRatio 1.93

Edgar->Model Mapping

Feature Distribution

Change over Time